BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26514620)

  • 21. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
    Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
    J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
    Kalim KW; Basler M; Kirk CJ; Groettrup M
    J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis.
    Guan H; Nagarkatti PS; Nagarkatti M
    J Immunol; 2011 Jun; 186(12):6955-64. PubMed ID: 21551360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling.
    Chang J; Burkett PR; Borges CM; Kuchroo VK; Turka LA; Chang CH
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2270-5. PubMed ID: 23341605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection.
    Panzer M; Sitte S; Wirth S; Drexler I; Sparwasser T; Voehringer D
    J Immunol; 2012 Jan; 188(2):615-23. PubMed ID: 22156341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
    Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
    Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.
    Tan YV; Abad C; Wang Y; Lopez R; Waschek JA
    PLoS One; 2013; 8(4):e61200. PubMed ID: 23613811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis.
    Hou H; Sun Y; Miao J; Gao M; Guo L; Song X
    J Neuroimmunol; 2021 Jul; 356():577583. PubMed ID: 33940233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon monoxide-releasing molecule-A1 inhibits Th1/Th17 and stimulates Th2 differentiation in vitro.
    Nikolic I; Vujicic M; Stojanovic I; Stosic-Grujicic S; Saksida T
    Scand J Immunol; 2014 Aug; 80(2):95-100. PubMed ID: 24845722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development.
    Bassil R; Zhu B; Lahoud Y; Riella LV; Yagita H; Elyaman W; Khoury SJ
    J Immunol; 2011 Sep; 187(5):2322-8. PubMed ID: 21813770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The latest TH17 lymphocyte in the family of T CD4+ lymphocytes].
    Essakalli M; Brick C; Bennani N; Benseffaj N; Ouadghiri S; Atouf O
    Pathol Biol (Paris); 2010 Dec; 58(6):437-43. PubMed ID: 19299092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma.
    McAlees JW; Lajoie S; Dienger K; Sproles AA; Richgels PK; Yang Y; Khodoun M; Azuma M; Yagita H; Fulkerson PC; Wills-Karp M; Lewkowich IP
    Eur J Immunol; 2015 Apr; 45(4):1019-29. PubMed ID: 25630305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function.
    Niedbala W; Besnard AG; Jiang HR; Alves-Filho JC; Fukada SY; Nascimento D; Mitani A; Pushparaj P; Alqahtani MH; Liew FY
    J Immunol; 2013 Jul; 191(1):164-70. PubMed ID: 23720815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression.
    Liu HP; Cao AT; Feng T; Li Q; Zhang W; Yao S; Dann SM; Elson CO; Cong Y
    Eur J Immunol; 2015 Apr; 45(4):1010-8. PubMed ID: 25605286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.
    Gulen MF; Kang Z; Bulek K; Youzhong W; Kim TW; Chen Y; Altuntas CZ; Sass Bak-Jensen K; McGeachy MJ; Do JS; Xiao H; Delgoffe GM; Min B; Powell JD; Tuohy VK; Cua DJ; Li X
    Immunity; 2010 Jan; 32(1):54-66. PubMed ID: 20060329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.
    Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC
    J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
    Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
    Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.